58 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
the rights of shareholders in typical U.S. corporations.
Holders of our ADSs may not have the same voting rights as the holders of our ordinary shares … shareholders and in accordance with the provisions of the deposit agreement, will not be able to exercise voting rights attaching to the ordinary shares
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
with him are interested) carry 30% or more of the voting rights of a company; or
any person who, together with persons acting in concert with him … , is interested in shares which in the aggregate carry not less than 30% of the voting rights of a company but does not hold shares carrying more than 50
8-K
EX-10.3
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
, of any voting rights available to Company shareholders generally pursuant to any transaction described in Section 2(a) above, provided that the Investor … violated this Section 2(b);
(iii) the exercise by the Investor and/or its Affiliates, if applicable, of any voting rights generally available to it or them
S-3ASR
AUTL
Autolus Therapeutics plc
7 Feb 24
Automatic shelf registration
10:00pm
, and in which persons acting in concert with him are interested) carry 30% or more of the voting rights of a company; or
any person who, together with persons … acting in concert with him, is interested in shares which in the aggregate carry not less than 30% of the voting rights of a company but does not hold
S-3ASR
EX-4.9
AUTL
Autolus Therapeutics plc
7 Feb 24
Automatic shelf registration
10:00pm
the payment of dividends or distributions, if any, on the Warrant Securities or to exercise any voting rights, except to the extent expressly set … , on the Warrant Securities (except to the extent set forth in the Warrant Agreement) or to exercise any voting rights.
Reference is hereby made to the further
6-K/A
EX-99.2
a6bu7
6 Jul 23
Current report (foreign) (amended)
5:38pm
6-K
EX-99.2
2ohisf544psw7m
6 Jun 23
Current report (foreign)
8:18am
424B5
x4esjo
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
5enqusqtop ax
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
0o18xs4u5pl
1 Jul 22
Current report (foreign)
5:15pm
6-K
EX-99.1
152sou9ytssu3
1 Jun 22
Current report (foreign)
5:19pm
F-6EF
EX-99
81wxnjk
9 Nov 21
Automatic registration for ADRs (foreign)
4:02pm
6-K
EX-99.1
76jzkau85s jo1jsxp
8 Nov 21
Securities Purchase Agreement
5:28pm
424B5
c8cfqkjf
19 Aug 21
Prospectus supplement for primary offering
4:13pm
F-3
EX-4.6
ty0c89p31gm
6 Aug 21
Shelf registration (foreign)
2:30pm
F-3
dlns1k kedtqk6a2
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-2
mnhy4egbwf2t1g 60n
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1
uptw9ap60mwdttia8
30 Jun 21
Annual Report and Accounts
6:05am